PHITONEX

Phitonex, Inc. is developing the next generation of fluorescent labels and instrumentation to advance the fight against disease. Phitonex reagents provide a cost-effective, non-destructive method to obtain more information about critical molecular biomarkers, simplifying experimental design and accelerating the discovery process. As a Duke University spin-out, the company’s co-founders have over 15 years of collaborative experience engineering labels at the molecular level to tailor their fluorescence properties.